St. Jude proceeds with study of next-gen CRT defibrillator

05/3/2013 | MassDevice.com (Boston)

St. Jude Medical has begun patient enrollment in a U.S. study of its Quadra Assura MP system, a next-generation cardiac resynchronization therapy defibrillator for multipoint pacing. The trial, which will involve more than 500 participants, will test whether the device can be used in patients who may not benefit from or respond to traditional CRT single-point pacing.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC